Analysed VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) News Sources
Voyager ASGCT Late Breaker: Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 3-Month GLP Toxicology Data; Clinical Trial in Alzheimer’s Disease Expected H2 2026
13-05-2026
yahoo.com
Voyager Receives FDA IND Clearance for VY1706, First Gene Therapy Approach to Reducing Tau Production in the Brain for Alzheimer’s Disease
01-06-2026
yahoo.com
Here's Why We're A Bit Worried About Voyager Therapeutics' (NASDAQ:VYGR) Cash Burn Situation
09-06-2026
yahoo.com
Voyager to Present at H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference
11-06-2026
yahoo.com
Voyager’s Tau-Targeted Gene Therapy VY1706 for Alzheimer’s Disease to Be Featured in Developing Topics Poster Presentation at AAIC 2026
29-06-2026
yahoo.com
Voyager Therapeutics (VYGR) is Amongst the Best Stocks Under $10, With More Than 50% Upside
30-06-2026
yahoo.com
Cramer to a 23-Year-Old: Buy It, but It Might Take a ‘Lifetime’ to Make Money
02-07-2026
247wallst.com
What is the current price of VOYAGER THERAPEUTICS INC (VYGR:NASDAQ)?
The current price of VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) is $3.04.
VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) absolute price change since previous trading day?
The absolute price change of VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) since the previous trading day is $-0.16.
VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) percentage price change since previous trading day?
The percentage price change of VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) since the previous trading day is -5%.
What is the most recent average sentiment score for VOYAGER THERAPEUTICS INC (VYGR:NASDAQ)?
The most recent average sentiment score for VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for VOYAGER THERAPEUTICS INC (VYGR:NASDAQ)?
The most recent sentiment for VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) is .
SEC-8K** Filing Available For VOYAGER THERAPEUTICS INC (VYGR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.